193 related articles for article (PubMed ID: 14567646)
1. Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.
Conjeevaram R; Chaturvedula A; Betageri GV; Sunkara G; Banga AK
Pharm Res; 2003 Sep; 20(9):1496-501. PubMed ID: 14567646
[TBL] [Abstract][Full Text] [Related]
2. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
Fatouros DG; Bouwstra JA
J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
[TBL] [Abstract][Full Text] [Related]
3. Relationship between amount of beta-blockers permeating through the stratum corneum and skin irritation after application of beta-blocker adhesive patches to guinea pig skin.
Kobayashi I; Hosaka K; Ueno T; Maruo H; Kamiyama M; Konno C; Gemba M
Biol Pharm Bull; 1997 Apr; 20(4):421-7. PubMed ID: 9145222
[TBL] [Abstract][Full Text] [Related]
4. Transdermal delivery of beta-blockers.
Aqil M; Sultana Y; Ali A
Expert Opin Drug Deliv; 2006 May; 3(3):405-18. PubMed ID: 16640500
[TBL] [Abstract][Full Text] [Related]
5. Experimental verification of the mechanistic model for transdermal transport including iontophoresis.
Hirvonen J; Murtomäki L; Kontturi K
J Control Release; 1998 Dec; 56(1-3):169-74. PubMed ID: 9801440
[TBL] [Abstract][Full Text] [Related]
6. Propranolol hydrochloride-loaded liposomal gel for transdermal delivery: Characterization and in vivo evaluation.
Guan Y; Zuo T; Chang M; Zhang F; Wei T; Shao W; Lin G
Int J Pharm; 2015 Jun; 487(1-2):135-41. PubMed ID: 25882014
[TBL] [Abstract][Full Text] [Related]
7. In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species.
Kanikkannan N; Singh J; Ramarao P
J Control Release; 2001 Mar; 71(1):99-105. PubMed ID: 11245911
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of metoprolol. II: In-vitro skin permeation and bioavailability in hairless rats.
Ghosh TK; Adir J; Xiang SL; Onyilofur S
J Pharm Sci; 1995 Feb; 84(2):158-60. PubMed ID: 7738793
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of timolol by electroporation through human skin.
Denet AR; Préat V
J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
[TBL] [Abstract][Full Text] [Related]
10. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study.
Morsi NM; Aboelwafa AA; Dawoud MHS
J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602
[TBL] [Abstract][Full Text] [Related]
12. Effect of lipophilicity on in vivo iontophoretic delivery. II. Beta-blockers.
Tashiro Y; Sami M; Shichibe S; Kato Y; Hayakawa E; Itoh K
Biol Pharm Bull; 2001 Jun; 24(6):671-7. PubMed ID: 11411557
[TBL] [Abstract][Full Text] [Related]
13. Transdermal iontophoretic delivery of timolol maleate in albino rabbits.
Kanikkannan N; Singh J; Ramarao P
Int J Pharm; 2000 Mar; 197(1-2):69-76. PubMed ID: 10704794
[TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach.
Denet AR; Ucakar B; Préat V
Pharm Res; 2003 Dec; 20(12):1946-51. PubMed ID: 14725358
[TBL] [Abstract][Full Text] [Related]
15. Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization.
Aqil M; Sultana Y; Ali A; Dubey K; Najmi AK; Pillai KK
Drug Deliv; 2004; 11(1):27-31. PubMed ID: 15168788
[TBL] [Abstract][Full Text] [Related]
16. Effect of lipophilicity on microneedle-mediated iontophoretic transdermal delivery across human skin in vitro.
Pawar KR; Smith F; Kolli CS; Babu RJ
J Pharm Sci; 2013 Oct; 102(10):3784-91. PubMed ID: 23955316
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation.
Ahmed S; Imai T; Otagiri M
Pharm Res; 1996 Oct; 13(10):1524-9. PubMed ID: 8899845
[TBL] [Abstract][Full Text] [Related]
18. Carboxymethylcellulose-sodium based transdermal drug delivery system for propranolol.
Krishna R; Pandit JK
J Pharm Pharmacol; 1996 Apr; 48(4):367-70. PubMed ID: 8794984
[TBL] [Abstract][Full Text] [Related]
19. Formulation study of a patch containing propranolol by design of experiments.
Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
[TBL] [Abstract][Full Text] [Related]
20. Enhancement and mechanism of transdermal absorption of terpene-induced propranolol hydrochloride.
Cui Y; Li L; Zhang L; Li J; Gu J; Gong H; Guo P; Tong W
Arch Pharm Res; 2011 Sep; 34(9):1477-85. PubMed ID: 21975809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
